Glaucoma start-up gains $16m for implant trial
MELBOURNE: Glaucoma affects an estimated 70 million people worldwide and a Melbourne based biotech, PolyActiva,
MELBOURNE: Glaucoma affects an estimated 70 million people worldwide and a Melbourne based biotech, PolyActiva,
FEATURED
Thousands of over-50s are choosing to embark on a ‘second career’
Elderly who rent their homes have shorter life expectancy
Developer to combine boomer apartments with quality retail
Seniors housing provider embraces vertical living trend
Best retirement housing design for Global Awards shortlisted
Plans revealed for three new multigenerational towers to transform area
INNOVATION
